Advertisement
Screener

XBIOTECH INC. (XBIT) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

XBIOTECH INC. Cash Flow Breakdown

Cash flow breakdown shows where XBIOTECH INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $39.92M went out.
  • Fiscal year ended 2025-12-31: from investing, $289.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $10.25M went out.
  • Fiscal year ended 2025-12-31: change in cash, $47.13M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDividendsNew shares soldNot split outChange in cash
2025-12-31-$39.92M-$289.00K-$10.25M*-$47.13M
2024-12-31-$30.96M-$1.30M$0.00$200.00K$10.25M*-$27.35M
2023-12-31-$18.73M$61.50M-$14.00K$4.80K$42.72M
2022-12-31-$14.82M-$63.89M$0.00$0.00-$79.68M
2021-12-31$69.44M-$3.52M-$75.00M$8.00M-$383.00K
2020-12-31-$65.15M-$3.73M$0.00$10.30M-$420.02M*-$477.23M
2019-12-31-$18.27M$674.80M$0.00$3.80M$38.30M*$698.77M
2018-12-31-$16.54M-$122.00K$401.00K-$15.95M
2017-12-31-$33.65M-$1.41M$703.00K$32.62M*-$2.56M
2016-12-31-$46.02M-$13.91M$1.10M$1.84M*-$56.73M
2015-12-31-$33.31M-$10.39M$77.47M*$33.72M
2014-12-31-$11.70M-$1.40M$63.20M*$50.09M
2013-12-31-$8.91M-$59.00K$12.04M*$3.08M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDividendsNew shares soldNot split outChange in cash
2026-06-30-$4.51M*-$4.00K*
2026-03-31-$8.97M$9.00K-$10.09M
2025-12-31-$22.95M*-$34.00K*
2025-09-30-$4.26M*-$110.00K*
2025-06-30-$5.99M*-$51.00K*
2025-03-31-$6.72M-$94.00K-$10.25M*-$16.78M
2024-12-31-$6.54M*-$84.00K*$0.00*$33.00K*
2024-09-30-$5.84M*-$338.00K*$0.00*$64.00K*
2024-06-30-$11.38M*-$627.00K*$48.00K*
2024-03-31-$7.20M-$255.00K$55.00K$10.00M*$1.02M
2023-12-31-$3.43M*-$115.00K*$0.00*
2023-09-30-$1.49M*$61.83M*$0.00*
2023-06-30-$9.00M*-$208.00K*
2023-03-31-$4.81M-$6.00K-$4.82M
2022-12-31-$3.16M*-$3.91M*$0.00*$0.00*
2022-09-30-$1.15M*-$59.74M*$0.00*
2022-06-30-$5.39M*-$82.00K*
2022-03-31-$5.12M-$161.00K-$5.16M
2021-12-31-$1.76M*-$476.00K*$0.00*$0.00*
2021-09-30-$3.40M*-$700.00K*$2.90M*-$74.94M*
2021-06-30$72.80M*-$1.71M*$4.10M*
2021-03-31$1.81M-$637.00K$1.00M$2.51M
2020-12-31-$391.00K*-$2.22M*$0.00*-$100.00K*
2020-09-30$7.48M*-$694.00K*$2.10M*
2020-06-30-$11.57M*-$426.00K*$400.00K*
2020-03-31-$60.67M-$389.00K-$412.08M*-$473.05M
2019-12-31-$3.75M*$674.99M*$3.17M*$674.26M*
2019-09-30-$4.98M*-$161.00K*-$4.58M*
2019-06-30-$4.86M*-$31.00K*$296.00K*$37.60M*$32.90M*
2019-03-31-$4.68M-$6.00K$643.00K-$3.80M
2018-12-31-$5.12M*-$8.00K*-$5.03M*
2018-09-30-$4.00M*-$32.00K*$300.00K-$4.00M*
2018-06-30-$3.90M*-$48.00K*$0.00*-$3.57M*
2018-03-31-$3.53M-$34.00K$201.00K-$3.35M
2017-12-31-$6.81M*-$254.00K*-$7.21M*
2017-09-30-$6.47M*-$261.00K*-$6.97M*
2017-06-30-$8.47M*-$283.00K*$454.00K-$8.68M*
2017-03-31-$11.91M-$607.00K$32.71M*$20.31M
2016-12-31-$12.80M*-$1.97M*$200.00K*$1.88M*-$12.47M*
2016-09-30-$15.02M*-$3.17M*-$18.00M*
2016-06-30-$8.25M*-$5.86M*-$13.43M*
2016-03-31-$9.95M-$2.92M-$12.83M
2015-12-31-$10.70M*-$3.75M*-$14.63M*
2015-09-30-$7.22M*-$4.44M*-$11.70M*
2015-06-30-$8.86M*-$1.64M*$700.00K$74.63M*$65.15M*
2015-03-31-$6.53M-$571.00K$2.11M*-$5.09M
2014-12-31-$3.45M*-$551.00K*$45.85M*$41.83M*
2014-09-30-$3.23M*-$529.00K*$5.75M*$2.09M*
2014-06-30-$2.68M*-$259.00K*-$2.96M*
2014-03-31-$2.34M-$58.00K$11.61M*$9.12M

Similar stocks

Stock NameCountryMarket CapPE Ratio
HYPERION DEFI, INC. (HYPD)United States$0.065B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95